The independent source for health policy research, polling, and news.
5,821 - 5,840 of 15,454 Results
What began in India as a populist movement to bring inexpensive morphine to the diseased and dying poor has paved the way for a booming pain management industry. Now, new customers are being funneled to U.S. drugmakers bedeviled by a government crackdown back home.
In Utah, 85% of deaths from firearms are suicides. To help people who might be vulnerable, outreach workers are discussing suicide prevention at gun shows and firearms classes.
Doctors who saw patients with a mysterious lung illness in the past suspected vaping as the cause but didn’t know where to report such cases.
Congress has a variety of reforms in mind that could roil the drugmaking business and potentially slash prices.
Confusion about a new federal rule to restrict legal immigration based on the use of public benefits may dampen sign-ups for health care, housing and food aid even among immigrants not directly targeted by the rule. Here are some answers to frequently asked questions that will help clear up some of the misunderstanding.
The state judge ruled that drugmaker Johnson & Johnson contributed to the opioid epidemic that has claimed the lives of 6,000 Oklahomans.
Talking about your mental health on social media is a thing, and it could actually help.
Wyoming is taking on expensive air ambulance bills by trying to expand Medicaid to cover transport for all patients. This is a big change: a red state seeking to control what's been a growing free-market bonanza.
In response to recent high-profile sex abuse cases, some California lawmakers want doctors to give patients more information about pelvic exams, and then get a signature proving they did. Doctors in the Golden State and beyond are pushing back.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
An amino acid infusion called NAD is not approved by the FDA to treat addiction. Yet patients with addiction can be desperate enough to try it, at prices as high as $15,000.
In an exclusive interview, a West Virginia physician says that back in 2015 he had a sense a patient’s illness “probably wasn't the first case ever seen nor would it be the last.” Was it a sentinel event?
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Dialysis companies are fighting a bill in the California legislature that could disrupt their business model. Their weapons: campaign cash and a sophisticated public relations campaign.
Before “Medicare for All,” there was just Medicare, the federal program that provides insurance to 60 million Americans. This week, KHN’s Julie Rovner talks to Tricia Neuman of the Kaiser Family Foundation about how Medicare works and whom it serves. Then, Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Kimberly Leonard of the Washington Examiner join Rovner to talk about some current Medicare issues being debated in Washington, D.C.
What changes are needed to bring home dialysis to more patients — especially older adults, the fastest-growing group of patients with serious, irreversible kidney disease? We asked nephrologists, patient advocates and dialysis company officials for their thoughts.
Americans routinely skirt federal law by crossing into Canada and Mexico or tapping online pharmacies abroad to purchase prescription medications at a fraction of the price they would pay at home. Is it safe? Not necessarily. Here’s some advice.
For nearly 50 years, cigarette advertising has been banned from TV and radio. But the marketing of electronic cigarettes isn’t constrained by that law.
MDMA, the psychoactive ingredient in the club drug known as molly or ecstasy, is being tested in combination with therapy as a treatment for severe trauma.
The Trump administration's policy shift on Title X family planning funds is likely to make birth control harder to get and more expensive for low-income women. It will also shift funds from organizations like Planned Parenthood to the Obria Group, which does not give women hormonal contraceptives or condoms in its clinics.
© 2026 KFF